biosaxony – The Biotechnology, Medical Technology & Health Economy Cluster in Saxony

Section biotechnology - Your network for biotechnology in Saxony

Section medical technology - Your network for medical technology in Saxony

Section health economy - Your network for health economy in Saxony

biosaxony is the association of the biotechnology, medical technology and health economy sector in the region of Saxony. Its members represent the various companies, scientific institutions and lobbyists working in biotechnology and medtech and the related areas of engineering and material sciences in Saxony. The network is complemented by representatives from the user side, for example clinics and health insurance companies. The network combines the strengths of all member companies and represents their interests in politics and the public. The cluster's tasks include initiating projects between industry and science, providing services and know-how, and presenting regional competencies in order to support the value-added expansion of these cross-sectional technologies and strengthen the economic region of Saxony. In addition, the promotion of young innovative companies is one of the main concerns of the network.

Join us!

Subscribe to our newsletter

Always stay up to date!

Sponsor Members of biosaxony e.V.

NEWS

Radiopharmacy: Radiation made in Saxony - Saxon radiopharmacy network nukliD® strengthens international visibility

Today, Thursday 16 January 2025, leading German and international players in the field of radiopharmacy from Saxony agree to intensify their collaboration. The aim of the partners from the fields of research, industry and cluster management is to develop radiopharmacy in Saxony into a centre of innovation and expertise in this pioneering field and thus make it more visible internationally. To this end, have joined forces under the name Radiopharmacy Cluster Dresden - nukliD®.

Credits: Jürgen Lösel

Ministerpräsident Michael Kretschmer mit den Begründern vom neuen Radiopharmacy Cluster Dresden- nukliD. v.l.n.r.:Andreas Kluge, ABX CRO; Jakub Simecek, Trimt GmbH; Felix Husmann, EZAG Isotop technologies Dresden GmbH, Dr. Björn Wolf, HZDR; Michael Kretschmer, Ministerpräsident Sachsen; André Hofmann, biosaxony Management GmbH; Dr. Gunnar Mann, EZAG Gamma Service Recyling GmbH; Dr. Marco Müller, ABX biochemical compounds; Dr. Dirk Freitag-Stechl, CUP Contract Labs; Jens Junker, Rotop Pharmaka Gmbh; Dr. Wilhelm Zörgiebel, MDG- Molecular Diagnostic GroupGmbH